Absci Corporation Common Stock
ABSI
ABSI: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
moreShow ABSI Financials
Recent trades of ABSI by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ABSI's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: C-peptides and proinsulin polypeptides comprising the same Feb. 21, 2023
-
Patent Title: Host cells for use in an inducible coexpression system Sep. 20, 2022
-
Patent Title: Vectors for use in an inducible coexpression system Jun. 28, 2022
-
Patent Title: Coordinated coexpression of thrombin Dec. 17, 2019
-
Patent Title: Inducible coexpression system Apr. 11, 2017
Federal grants, loans, and purchases
Followers on ABSI's company Twitter account
Number of mentions of ABSI in WallStreetBets Daily Discussion
Recent insights relating to ABSI
Recent picks made for ABSI stock on CNBC
ETFs with the largest estimated holdings in ABSI
Flights by private jets registered to ABSI